Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis [Phase 3]
Phase 3 study of secukinumab in Ankylosing Spondylitis completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis [Phase 2]
Phase 2 trial evaluating different doses of bimekizumab in active ankylosing spondylitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients [Phase 4]
Phase 4 trial updates biomarkers associated with the efficacy of an anti-TNFα agent in ankylosing spondylitis.
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: Study to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis [Phase 4]
Phase 4 clinical trial update evaluating efficacy and NSAID-sparing effect of secukinumab in ankylosing spondylitis; results posted after co…
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis [Phase 4]
A Phase 4 clinical trial evaluating non-steroidal anti-inflammatory drugs in axial spondyloarthritis was terminated with results posted in 2…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis [Phase 2, Phase 3]
Clinical trial update for Bawei Shenqi Pill in ankylosing spondylitis, currently in Phase 2/Phase 3 with status unknown.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA [Phase 4]
Phase 4 trial update on withdrawal and re-treatment with etanercept in Nr-axial spondyloarthritis (nr-axial SpA) completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS) [Phase 1, Phase 2]
Phase 1/2a clinical trial of 99mTc-rhAnnexin V-128 in rheumatoid arthritis and ankylosing spondylitis; trial terminated with results posted …
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo [Phase 3]
A Phase 3 study assessing maintenance of sustained remission with CZP versus placebo in axial spondyloarthritis and ankylosing spondylitis h…
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis [Phase 3]
Phase 3 trial evaluating safety and efficacy of prefixed liquid etanercept (Yisaipu) for active ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade
A completed clinical trial evaluating post-marketing use of CT-P13 (infliximab) for standard care in patients with rheumatoid diseases who a…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
Clinical trial update on T cells and TNF blockade in inflammatory diseases; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Spondylitis Trial of Apremilast for Better Rheumatic Therapy [Phase 2]
Phase 2 clinical trial update for apremilast in ankylosing spondylitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)
Post-marketing observational study evaluating the impact of AbbVie's Patient Support Program on patient-reported outcomes and health resourc…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis [Phase 3]
Phase 3 trial update reports 16-week efficacy and 5-year long-term efficacy, safety, and tolerability of secukinumab in active ankylosing sp…
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 trial update evaluating a self-injection e-device for certolizumab pegol in several inflammatory diseases; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira [Phase 3]
Phase III trial evaluating BAT1406 compared with Humira in ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs [Phase 4]
A phase 4 clinical trial evaluating a treat-to-target strategy in ankylosing spondylitis using etanercept and conventional synthetic DMARDs.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis [Phase 3]
A Phase 3 trial evaluating efficacy and safety of secukinumab in Japanese patients with active ankylosing spondylitis has completed with res…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS [Phase 4]
Phase 4 trial update on sequential use of Yisaipu and DMARDs for treating mild-to-moderate ankylosing spondylitis.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Extension in AS: Sustainability of Benefits, Safety and Tolerability [Phase 3]
Phase 3 extension study update on sustainability of benefits, safety, and tolerability for AS (ankylosing spondylitis).
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta [Phase 1]
Phase 1 postmarketing transfer study evaluating Cimzia (certolizumab pegol) from mother to infant via placenta has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS) [Phase 2]
Phase 2 dose-finding study of risankizumab (BI 655066) in ankylosing spondylitis completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: The Effects of Nanocurcumin on Treg Cells and Th17 Cells Responses in Ankylosing Spondylitis Patients [Phase 2]
Phase 2 clinical trial investigating the effects of nanocurcumin on regulatory T and Th17 cell responses in patients with Ankylosing Spondyl…
-
CLINICAL_TRIALS trial_result · 2019-04-30Clinical Trial Update: A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis [Phase 4]
Phase 4 randomized trial evaluating Fengshigutong Capsule for ankylosing spondylitis.